Exclusive Summary

• Naloxone is the core first-line emergency antidote for overcoming the global opioid crisis, listed on the WHO Essential Medicines List, experiencing surging procurement demand driven by fentanyl abuse.
• With originator patents long expired, this product leverages China's integrated supply chain to offer exceptional cost advantages, making it ideal for winning government tenders and public health procurements.
• The 1ml:0.4mg strength is the classic standard presentation for hospitals and paramedics, serving as a highly reliable secondary source for overseas distributors amidst frequent global supply chain backorders.
• The supplier provides comprehensive, internationally compliant registration dossiers and robust quality systems to help overseas clients achieve rapid local regulatory approvals and penetrate distribution networks.